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Abstract
The prevalence of atopic dermatitis (AD) in school-age children has increased in industrialized countries. As diet is one of the main factors 
provoking AD, some studies have suggested that food additives in processed foods could function as pseudoallergens, which comprise the non-immunoglobulin
E-mediated reaction. Eosinophil cationic protein (ECP) is an eosinophil granule protein released during allergic reactions to food allergens in patients
with AD. Thus, serum ECP levels may be a useful indicator of ongoing inflammatory processes in patients with AD. The purpose of this study 
was to investigate the effect of consuming MSG in processed foods on serum ECP levels among children with AD. This study was performed 
with 13 patients with AD (age, 7-11 years) who had a normal range of total IgE levels (< 300 IU/ml). All participants ate normal diets during
the first week. Then, six patients were allocated to a processed food-restricted group (PRDG) and seven patients were in a general diet group (GDG).
During the second week, children in the PRDG and their parents were asked to avoid eating all processed foods. On the third week, children in
the PRDG were allowed all foods, as were the children in the GDG throughout the 3-week period. The subjects were asked to complete a dietary
record during the trial period. Children with AD who received the dietary restriction showed decreased consumption of MSG and decreased serum
ECP levels and an improved SCORing score on the atopic dermatitis index (P< 0.05). No differences in serum ECP levels or MSG consumption 
were observed in the GDG. Serum total IgE levels were not changed in either group. In conclusion, a reduction in MSG intake by restricting
processed food consumption may lead to a decrease in serum ECP levels in children with AD and improve AD symptoms.
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Introduction7)
The prevalence of atopic dermatitis (AD) in children has 
increased in industrialized countries and is related to the 
Westernization of food habits and environmental pollution [1,2]. 
Various genetic, dietary, and environmental factors are potential 
risks provoking AD. Among these, diet is one of the main factors 
in patients presenting with symptoms of AD [3].
The use of convenient processed foods is common. Evidence 
is growing that these foods may cause adverse reactions, 
including immunological hypersensitivity [4]. The prevalence of 
adverse reactions to food additives is up to 2% in children [5] 
and this increases to 7% in children with AD [6]. Numerous 
studies have shown that foods such as cow’s milk and hen’s 
eggs directly provoke atopic symptoms in children with AD [7-9]. 
Although the safety of processed foods for children with AD 
remains controversial, current research on the safety of processed 
food consumed by children with AD is insufficient. 
Food additives are classified by function, such as antioxidants, 
colorings, emulsifiers, flavorings, taste enhancers, preservatives, 
and stabilizers [4]. Monosodium glutamate (MSG) is a salt that 
forms glutamic acid, has unique flavor-enhancing qualities, and 
is widely used as a food additive [10]. MSG is a popular flavor 
enhancer and is added to many foods, particularly Asian dishes 
[11]. The average intake in a meal can be 3-5 g, with widely 
variable daily intake that may reach 12 g in some countries [12]. 
After Kwok reported the clinical MSG reaction called “Chinese 
restaurant syndrome” in 1968 [13], some studies suggested that 
MSG intake was positively associated with inflammatory disease 
[13,14]. However, other studies reported no significant adverse 
reactions in healthy individuals when up to 3 g MSG is given 
with food [15].
One recent study reported that AD is associated with food 
allergy [8] and that the prevalence of food allergy is 50% in 
patients with AD [16]. A food allergy is an immune-mediated 
food intolerance. The mechanism of immune-mediated adverse 
reactions may be divided into immunoglobulin (Ig)-E mediated 
or immediate-in-time and non-IgE-mediated or delayed-in-time 
responses [4,17]. This categorization has been extended by 
creating a third subgroup of mixed IgE- and non-IgE-mediated 
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Allowed Forbidden
Basic food Rice, unprocessed food,
preservative-free bread
All others (e.g. noodles)
Fat Cold processed plant oil All others (e.g. margarine)
Milk products Fresh milk, white cheese All others
Meat, fish, eggs Fresh meat, sea-food, eggs All others (e.g. canned meat 
and fish, processed meat)
Vegetables All -
Fruits Fresh fruit Canned fruit, processed fruit 
containing preservation
Herbs, spices Salt, sugar, chives All others
Sweets None except honey, 
oligosaccharide
All (chewing gum)
Beverages Milk, water All others
T h is  t a b l e  is  b a s e d  o n  Z u b e r b ie r  et  al. [ 2 8 ] .
Table 1. Forbidden foods in the processed food-restricted group: All foods 
containing food additives and industrially processed food
disorders such as AD, allergy asthma, and eosinophilic esophagitis 
[7,18]. Some studies have suggested a mechanism that associates 
non-IgE-mediated or delayed-in-time responses with food additives 
[9,19]. 
Eosinophils are important as effecter cells in AD allergic 
inflammation because they migrate from the blood into lesional 
skin. Eosinophils participate in the complex regulatory system 
that mediates inflammatory responses [20]. Eosinophil cationic 
protein (ECP) is one of the eosinophil granule proteins released 
during an allergic reaction in patients with AD. Czech et al. [21] 
showed that ECP had a higher correlation with total clinical score 
such as lichenification, loss of sleep, erythema, papules, pruritus, 
and excoriations than immunological parameters such as total 
IgE. Measuring serum ECP levels may be a useful indicator of 
eosinophil activity during ongoing inflammatory processes. In 
previous studies of adult and young patients with AD, ECP levels 
were elevated and significantly correlated with disease severity 
[22-25]. 
The present study investigated the effects of consuming MSG 
in processed foods on the serum level of ECP among school 
children diagnosed with AD who had a normal range of serum 
total IgE levels.
Subjects and Methods
Study design
This study was performed with 13 patients with AD (age, 7-11 
years old). All patients met the diagnostic criteria for AD as 
defined by Hanifin and Rajka [26]. It has been suggested that 
adverse reactions to food additives are non-IgE-mediated [19,20]; 
therefore, subjects with a normal range of serum total IgE levels 
(< 300 IU/ml) were selected [27]. 
All participants ate their normal diet during the first week. 
Then, six patients were allocated to a processed food-restrict 
group (PRDG) and seven patients to a general diet group (GDG). 
During the second week, children in the PRDG and their parents 
were asked to avoid eating all processed foods listed in Table 
1 [28]. During the third week, subjects in the PRDG were allowed 
to eat all foods. Children in the GDG were allowed to eat all 
food throughout the experimental period.
All participants were asked to complete a daily dietary record 
during this period. Blood samples were collected on the first day 
of the experiment and at the end of each week for 2 or 3 weeks. 
The Ethical Committee of the Seoul Allergy and Immunology 
Association, Seoul, Korea approved the present study, and written 
informed consent was obtained from each patient’s parent.
Dietary assessment
Seven-day food intake dietary records were completed by all 
subjects. The dietary records were analyzed using the Computer 
Aided Nutritional Analysis Program III (Can Pro 3.0) developed 
by the Korean Nutrition Society. We estimated nutrient intake, 
frequency, and quantity of processed foods consumed for 1 week. 
The quantity of MSG consumed was estimated using the median 
value of MSG content in each food consumed, as indicated by 
the Korea Food and Drug Administration.
Measurement of serum ECP and total IgE levels 
Total IgE levels were determined by an ADVIA Centaur XP 
Systems instrument (Siemens, Munich, Germany). Blood samples 
were obtained on the first day of the trial period and at the end 
of each week. Serum ECP levels were measured by an EIA test 
method using the MESACUP ECP Test (Medical & Biological 
Laboratories, Nagano, Japan) according to the manufacturer’s 
guidelines.
Scoring atopic dermatitis 
To evaluate the clinical improvement in AD, every patient was 
assessed by a single observer and objectively scored for disease 
extent and severity using the SCORing Atopic Dermatitis 
(SCORAD) [29] at the end of each week for 3 weeks. 
Statistical analysis
Differences in daily nutrient intake of children in the PRDG 
and GDG were analyzed by the t-test. Baseline characteristics, 
total IgE, and serum ECP levels were analyzed with nonparametric 
tests. The Mann-Whitney U-test was used for unpaired analyses 
and Wilcoxon’s signed-rank test was used for paired analyses. 
Spearman’s correlation and Spearman’s partial rank-order correlation 
were used to determine the correlation between changes in serum 
ECP levels and MSG intake. Statistical analyses were performed 
using SPSS 17.0 (SPSS Inc., Chicago, IL, USA), and P-values 
< 0.05 were considered significant. 226 Food additives and allergy
PRDG
1) GDG
2)
Baseline End of 2 wk P Baseline End of 2 wk P
Energy (kcal) 1,579.13
3) ± 220.70 1,288.88 ± 208.39 0.000 1,668.92 ± 422.00 1,768.86 ± 409.01 0.238 
Total  protein  (g) 60.29 ± 11.26 47.56 ± 10.83 0.000 66.99 ± 17.01 66.48 ± 21.47 0.897 
Vegetable protein (g) 31.15 ± 7.15 24.41 ± 4.86  0.000  31.08 ± 8.36 34.15 ± 12.00  0.143 
Animal  protein  (g) 29.14 ± 9.38 23.15 ± 8.73  0.001 35.91 ± 12.59 32.33 ± 13.90 0.185 
Total  fat  (g) 43.03 ± 13.25 29.36 ± 9.54  0.000 48.82 ± 15.59 50.82 ± 19.07 0.571 
Vegetable fat (g) 20.69 ± 7.26 12.40 ± 5.10  0.000  21.59 ± 8.06 22.78 ± 12.83  0.582 
Animal  fat  (g) 22.34 ± 10.09 16.96 ± 7.22  0.002 27.22 ± 13.62 28.03 ± 13.06 0.762 
Carbohydrate  (g) 240.17 ± 37.33 209.37 ± 35.91 0.000 240.41 ± 63.22 264.65 ± 56.17 0.048 
Fiber  (g) 17.13 ± 4.03 13.37 ± 3.31 0.000 16.27 ± 5.57 17.63 ± 5.03 0.208 
Ash (g) 16.32 ± 5.15 13.55 ± 5.26  0.008  16.61 ± 4.6 19.46 ± 7.90  0.030 
Total calcium (mg) 512.67 ± 171.47 372.34 ± 148.98  0.000  605.35 ± 288.21 654.32 ± 264.45  0.384 
Vegetable calcium (mg) 264.43 ± 69.48 173.37 ± 46.77  0.000  239.95 ± 90.73 261.10 ± 116.23  0.321 
Animal calcium (mg) 248.24 ± 166.26 198.96 ± 152.75  0.119  365.40 ± 231.69 393.22 ± 204.89  0.532 
Phosphorus (mg) 892.24 ± 196.92 705.99 ± 162.94  0.000  987.69 ± 295.86 1,030.03 ± 341.28  0.512 
Total  iron  (mg) 12.15 ± 2.80 8.78 ± 2.00  0.000 11.79 ± 3.36 11.84 ± 3.37 0.952 
Vegetable iron (mg) 9.12 ± 2.58 6.48 ± 1.36  0.000  8.70 ± 2.97 9.12 ± 3.01  0.490 
Animal  iron  (mg) 3.03 ± 1.44 2.30 ± 1.38 0.010 3.10 ± 1.13 2.72 ± 1.20 0.112 
Sodium (mg) 3,463.85 ± 1,086.03 2,599.43 ± 792.84  0.000  3,407.25 ± 1,141.1 3,738.00 ± 1,096.21  0.146 
Potassium (mg) 2,487.40 ± 781.27 1962.02 ± 421.85  0.000  2,331.28 ± 781.17 2,621.35 ± 746.14  0.064 
Zinc  (mg) 9.20 ± 10.18 6.63 ± 1.64 0.078 7.81 ± 2.18 8.44 ± 2.39 0.172 
Vitamin A (μg  RE)  765.42 ± 272.71 527.18 ± 211.73 0.000 719.24 ± 351.79 712.89 ± 266.64 0.920 
Retinol (μg) 151.57 ± 127.70 100.56 ± 69.27 0.013  166.84 ± 94.2 192.08 ± 120.81  0.250 
β-carotene (μg) 3,457.03 ± 1,508.42 2,481.41 ± 1,139.13 0.000  2,923.80 ± 1691.5 2,785.14 ± 1,379.22 0.659 
Vitamin B1  (mg) 1.08 ± 0.31 0.78 ± 0.19 0.000 1.15 ± 0.51 1.17 ± 0.40 0.810 
Vitamin B2  (mg) 1.01 ± 0.32 0.77 ± 0.22 0.000 1.27 ± 0.64 1.19 ± 0.42 0.479 
Vitamin B6  (mg) 1.76 ± 0.51 1.50 ± 0.38 0.004 1.75 ± 0.70  1.75 ± 0.55 0.997 
Niacin  (mg) 13.61 ± 4.22 11.42 ± 3.46 0.005 13.55 ± 5.98 13.99 ± 4.74 0.689 
Vitamin  C  (mg) 100.07 ± 61.79 60.55 ± 21.79 0.000 88.80 ± 66.86 78.36 ± 44.54 0.362 
Folic acid (μg) 221.27 ± 95.96 161.53 ± 42.10 0.000  201.584 ± 83.55 223.47 ± 75.89 0.179 
Vitamin E (mg) 12.55 ± 4.57 9.78 ± 4.12  0.002  11.91 ± 4.11 11.90 ± 4.65  0.994 
Cholesterol  (mg) 268.85 ± 141.12 249.39 ± 17.34  0.478 358.56 ± 175.66 315.33 ± 159.40 0.206 
1) PRDG,  processed  food  restricted  diet  group;  GDG,  general  diet  group
2) Paired  t-test 
3) All  values  are  mean ± SD. 
Table 3. Daily nutrient intake of the subjects 
Total
(n = 13)
PRDG¹
)
(n = 6)
GDG¹
(n = 7) P
2)
Age (yr) 8.77 ± 1.12
3) 8.33 ± 0.52 9.14 ± 1.46 0.289
Weight (kg) 29.02 ± 8.7 26.13 ± 4.97 31.49 ± 10.74 0.391
Height (cm) 128.77 ± 7.73 126.12 ± 6.42 131.04 ± 8.49 0.317
BMI 17.24 ± 3.1 16.29 ± 2.19 18.05 ± 3.68 0.475
Total IgE (IU/ml) 73.67 ± 59.19 52.42 ± 40.67 91.89 ± 69.21 0.116
ECP (µg/ml) 29.69 ± 9.63 25.33 ± 10.3 33.43 ± 7.86 0.199
SCORAD index 24.46 ± 9.52 25.66 ± 12.69 24.38 ± 7.48 0.784
1)  PRDG, processed food restricted diet group; GDG, general diet group; BMI, body 
mass index; IgE, immunoglobulin E; ECP, eosinophil cationic protein; SCORAD, 
SCORing  Atopic  Dermatitis  index
2) P-value  by  Mann-Whitney  U-test 
3) All  values  are  mean ± SD. 
Table 2. Baseline subject characteristics 
Results
Thirteen patients (nine females and four males; mean age, 8.77 
years; range, 7-11 years), who lived in Seoul, South Korea, 
participated in the study. Their mean body weight was 29.02 
kg, and mean height was 128.77 cm. Baseline serum ECP levels 
of all subjects were 29.69 ± 9.63 µg/ml, and total IgE levels were 
73.67 ± 59.19 IU/ml (Table 2).
No statistically significant differences were observed between 
children in the PRDG and GDG for daily nutrient intake after 
the first week. Daily nutrient intake of children in the PRDG 
decreased significantly after restricting processed foods during 
the second week. In contrast, daily nutrient intakes of children 
in the GDG were similar for the entire study period (Table 3). 
The estimated baseline MSG intake for children in the PRDG 
was 932.30 ± 230.70 mg/day. After restricting processed foods, 
MSG intake decreased significantly to 447.34 ± 123.83 mg/day 
(P = 0.028) during the second week. During the third week, 
children in the PRDG returned to a normal diet and their MSG 
intake increased to 749.37 ± 192.14 mg/day. In contrast, weekly 
changes in MSG intake were insignificant for children in the 
GDG during the trial period (Fig. 1). Ji Min Lee et al. 227
Fig. 1. Changes in MSG intake by restricting processed foods. PRDG, 
processed foods restricted diet group (n = 6); GDG, general diet group (n = 7). The 
Mann-Whitney  U-test  was  used  for  unpaired  analyses,  and  the  Wilcoxon 
signed-rank test was used for paired analyses. A P-value of <0.05 was considered 
significant.
Fig. 2. Changes in serum eosinophil cationic protein (ECP) levels by restricting 
processed foods. PRDG,  processed  foods  restricted  diet  group  (n = 6);  GDG, 
general  diet  group  (n = 7).  The  Mann-Whitney  U-test  was  used  for  unpaired 
analyses,  and  the  Wilcoxon  signed-rank  test  was  used  for  paired  analyses.  A 
P-value  of  < 0.05  was  considered  significant.
Fig. 3. Changes in serum total immunoglobulin-E (IgE) levels by restricting 
processed foods.  PRDG,  processed  foods  restricted  diet  group  (n = 6);  GDG, 
general  diet  group  (n = 7).  The  Mann-Whitney  U-test  was  used  for  unpaired 
analyses,  and  the  Wilcoxon  signed-rank  test  was  used  for  paired  analyses.  A 
P-value  of  < 0.05  was  considered  significant.
Fig. 4. Changes in the SCORing Atopic Dermatitis (SCORAD) index by 
restricting processed foods. PRDG, processed foods restricted diet group (n = 6); 
GDG, general diet group (n=7). The Mann-Whitney U-test was used for unpaired 
analyses,  and  the  Wilcoxon  signed-rank  test  was  used  for  paired  analyses.  A 
P-value  of  < 0.05  was  considered  significant.
Serum ECP levels in children in the PRDG decreased from 
25.33 ± 10.30 to 10.25 ± 8.09 µg/ml (P = 0.028) after restricting 
processed foods and increased to 44.75 ± 27.42 µg/ml on the third 
week when the restriction was lifted (Fig. 2). Total IgE levels 
did not change significantly in either group throughout the 
experimental period (Fig. 3).
The SCORAD index in the PRDG decreased from 23.53 ±
11.68 to 12.4 ± 6.01 then increased again when the children 
began consuming their usual diet. Serum ECP levels and the 
SCORAD index were not significantly different in the GDG 
between the first and second week. The pattern of changes not 
only in serum ECP levels but also the SCORAD index was 
similar to that of MSG intake (Fig. 4). A significant positive 
correlation was observed (r = 0.629, P= 0.028) between changes 
in serum ECP levels and MSG intake. Furthermore, this 
significant correlation remained (r = 0.774, P = 0.014) after 
adjusting for other nutrient factors, which were significantly 
correlated with serum ECP levels (r = 0.650 and P =0 . 0 2 2  f o r  
sodium; r = 0.727 and P = 0.007 for potassium; r = 0.587 and P
= 0.044 for fiber).
Discussion
Processed foods were restricted in children with AD to 
investigate the effect of food additives, such as MSG, on serum 
ECP levels. As a result, significant decreases in MSG intake 
occurred. Although some studies have suggested that restricting 
processed foods and food additives improves chronic urticaria 
[30,31], adverse reactions to foods and food additives have 
frequently been disputed as a cause for chronic urticaria [28]. 
After the processed food restriction, daily nutrient intakes 
decreased significantly in the PRDG. Decreased daily nutrient 
intake by restricting processed foods implied that children with 
AD consumed high amounts of processed foods in their normal 228 Food additives and allergy
diet and that they did not replace processed foods with 
non-processed foods during the dietary restriction period.
Previous research has suggested that people with allergies 
consume significantly higher amounts of processed foods, 
including high frequency intake of instant snack foods, which 
contain many types of food additives known to provoke atopic 
symptoms [32]. Among the many types of food additives, MSG 
is common in Korea as a flavor enhancer. Some studies have 
reported MSG intake is positively associated with inflammatory 
disease [13,14].
In the present study, ECP levels decreased after restricting 
processed foods containing MSG. Improvements in skin status 
and reduced ECP levels have been observed in patients with AD 
who were restricted from eating processed foods [33]. Paganelli 
et al. [20] measured serum ECP levels of 24 children with AD 
and observed higher levels of ECP compared to controls without 
AD. Studies have found that both the soluble interleukin-2 
receptor and serum ECP levels are significantly higher in patients 
with AD than in those with urticaria or normal controls. A 
significant correlation is found between clinical severity scores 
in patients with AD and serum ECP levels [22-24]. Furthermore, 
Czech et al. [21] suggested that clinical improvement is associated 
with a decrease in both the clinical score and serum ECP levels.
However, serum total IgE levels were not influenced by 
restricting processed food in either group of our study. The type 
of hypersensitivity reaction that is caused by food additives might 
be considered a pseudoallergic reaction [33]. Pseudoallergens 
induce histamine, tryptase, and other pro-inflammatory mediators 
produced by mast cells in vivo [34] The mechanisms are only 
partly understood, but they are apparently based on direct 
activation of mast cells. The pseudoallergic reaction is not 
IgE-mediated and does not require prior sensitization [35]. This 
may explain why total IgE levels of all subjects were not affected 
by food additives in the present study. 
We found a decrease in serum ECP levels by reducing dietary 
intake of MSG for 1 week. Further research should examine more 
closely whether high intakes of MSG provoke AD symptoms. 
This study had several limitations. Double-blind placebo 
controlled food challenges are the gold standard for confirming 
a food allergy [36]. As blinding of food containing MSG is very 
difficult, the present study did not include a food challenge. 
However, we showed a decrease in serum ECP levels by 
restricting processed food intake for 1 week among children with 
AD that increased to former levels when participants returned 
to their normal diets. 
Further studies are necessary to provide clear evidence of an 
association between MSG intake and increasing or decreasing 
serum ECP level or other cytokines.
In conclusion, serum ECP levels decreased following decreased 
intake of processed food, suggesting an improvement in 
inflammatory processes in children with AD. MSG influenced 
ECP levels but not IgE levels, suggesting that MSG may be 
involved non-IgE-mediated food allergies. 
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